- Corporate Officers - M
- Meeker David P
Insider Trading History of Meeker David P
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Meeker David P since 2008.
This trader's CIK number is 1385155.
At the time of last reporting, Meeker David P was the President and CEO of Rhythm Pharmaceuticals, Inc.. (stock ticker symbol RYTM).
Also see all insider trading activities at Rhythm Pharmaceuticals, Inc..
Note that in the past
Meeker David P also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Rhythm Pharmaceuticals, Inc. (RYTM) by Meeker David P
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | RYTM | 0 | $0 | 9,896 | $566,249 | 21,250 | $0 |
| 2024 | RYTM | 0 | $0 | 4,361 | $196,506 | 14,125 | $0 |
| 2021 | RYTM | 10,000 | $201,710 | 0 | $0 | 0 | $0 |
| 2017 | RYTM | 25,000 | $425,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Genzyme Corp (GENZ) by Meeker David P
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2011 | GENZ | 0 | $0 | 0 | $0 | 29,250 | $0 |
| 2010 | GENZ | 0 | $0 | 19,220 | $933,480 | 24,571 | $436,932 |
| 2009 | GENZ | 2,000 | $103,906 | 0 | $0 | 0 | $0 |
| 2008 | GENZ | 0 | $0 | 17,790 | $1,479,950 | 17,790 | $366,296 |
Yearly summary of insider trading at Myokardia, Inc. (MYOK) by Meeker David P
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | MYOK | 0 | $0 | 0 | $0 | 2,300 | $0 |
Yearly summary of insider trading at Trevi Therapeutics, Inc. (TRVI) by Meeker David P
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | TRVI | 0 | $0 | 4,555 | $13,350 | 4,555 | $6,513 |
| 2019 | TRVI | 11,250 | $112,500 | 0 | $0 | 0 | $0 |
Insider trading activities at 4 companies by Meeker David P:
1. Rhythm Pharmaceuticals, Inc. (RYTM)
2. Genzyme Corp (GENZ)
3. Myokardia, Inc. (MYOK)
4. Trevi Therapeutics, Inc. (TRVI)
Table 1. Insider trading of Rhythm Pharmaceuticals, Inc. (RYTM) by Meeker David P
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-02-16 | RYTM | Option Ex | 21,250 | .00 | 0 |
| 2025-02-19 | RYTM | Sale | 9,896 | 57.22 | 566,249 |
| 2024-02-01 | RYTM | Sale | 4,361 | 45.06 | 196,506 |
| 2024-02-01 | RYTM | Option Ex | 14,125 | .00 | 0 |
| 2021-03-30 | RYTM | Buy | 10,000 | 20.17 | 201,710 |
| 2017-10-10 | RYTM | Buy | 25,000 | 17.00 | 425,000 |
Table 2. Insider trading of Genzyme Corp (GENZ) by Meeker David P
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2011-04-04 | GENZ | Option Ex | 29,250 | .00 | 0 |
| 2010-05-25 | GENZ | Sale | 2,732 | 45.60 | 124,579 |
| 2010-05-24 | GENZ | Option Ex | 8,083 | .00 | 0 |
| 2010-05-21 | GENZ | Option Ex | 16,488 | 26.50 | 436,932 |
| 2010-05-21 | GENZ | Sale | 16,488 | 49.06 | 808,901 |
| 2009-04-23 | GENZ | Buy | 2,000 | 51.95 | 103,906 |
| 2008-08-15 | GENZ | Option Ex | 17,790 | 20.59 | 366,296 |
| 2008-08-15 | GENZ | Sale | 17,790 | 83.19 | 1,479,950 |
Table 3. Insider trading of Myokardia, Inc. (MYOK) by Meeker David P
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-06-13 | MYOK | Option Ex | 2,300 | .00 | 0 |
Table 4. Insider trading of Trevi Therapeutics, Inc. (TRVI) by Meeker David P
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-08-27 | TRVI | Option Ex | 4,555 | 1.43 | 6,513 |
| 2024-08-27 | TRVI | Sale | 4,555 | 2.93 | 13,350 |
| 2019-05-09 | TRVI | Buy | 11,250 | 10.00 | 112,500 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Meeker David P
(President and CEO of Rhythm Pharmaceuticals, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.